APO Research
Talk to an analyst

APO RESEARCH · REPORT

Niraparib API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Niraparib API Market Outlook and Growth Opportunities 2026

29 December 2025194 pages

Choose your research edition.

Industry ResearchNiraparib API Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Niraparib API Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Niraparib API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Niraparib API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Niraparib API Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Niraparib API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Niraparib API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Niraparib API market include Nantong Changyou Pharmaceutical Technology, Asymchem, WuXi STA, Valary Lab, SynZeal Research, Jigs chemical, Dr. Reddy's Laboratories and Bulat Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Niraparib API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Niraparib API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Niraparib API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Niraparib API market size, projected growth trends, production technologies, key applications, and end-use industries.

Niraparib API Segment by Company

Nantong Changyou Pharmaceutical Technology

Asymchem

WuXi STA

Valary Lab

SynZeal Research

Jigs chemical

Dr. Reddy's Laboratories

Bulat Pharmaceutical

Niraparib API Segment by Type

0.98

0.99

Niraparib API Segment by Application

Tablets

Capsules

Other

Niraparib API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Niraparib API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Niraparib API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Niraparib API significant trends, drivers, influence factors in global and regions.

6. To analyze Niraparib API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Niraparib API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Niraparib API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Niraparib API industry.

Chapter 3: Detailed analysis of Niraparib API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Niraparib API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Niraparib API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Niraparib API Industry Trends Table 2. Niraparib API Industry Drivers Table 3. Niraparib API Industry Opportunities and Challenges Table 4. Niraparib API Industry Restraints Table 5. Global Niraparib API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Niraparib API Revenue Share by Company (2021-2026) Table 7. Global Niraparib API Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Niraparib API Sales Volume Share by Company (2021-2026) Table 9. Global Niraparib API Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Niraparib API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Niraparib API Key Company Manufacturing Base & Headquarters Table 12. Global Niraparib API Company, Product Type & Application Table 13. Global Niraparib API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Niraparib API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.98 Table 18. Significant Companies of 0.99 Table 19. Global Niraparib API Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Niraparib API Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Niraparib API Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Niraparib API Sales Volume Share by Type (2021-2026) Table 23. Global Niraparib API Sales Volume Share by Type (2027-2032) Table 24. Global Niraparib API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Niraparib API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Niraparib API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Niraparib API Sales Value Share by Type (2021-2026) Table 28. Global Niraparib API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Tablets Table 30. Significant Companies of Capsules Table 31. Significant Companies of Other Table 32. Global Niraparib API Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Niraparib API Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Niraparib API Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Niraparib API Sales Volume Share by Application (2021-2026) Table 36. Global Niraparib API Sales Volume Share by Application (2027-2032) Table 37. Global Niraparib API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Niraparib API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Niraparib API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Niraparib API Sales Value Share by Application (2021-2026) Table 41. Global Niraparib API Sales Value Share by Application (2027-2032) Table 42. Global Niraparib API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Niraparib API Sales by Region (2021-2026) & (Tons) Table 44. Global Niraparib API Sales Market Share by Region (2021-2026) Table 45. Global Niraparib API Sales by Region (2027-2032) & (Tons) Table 46. Global Niraparib API Sales Market Share by Region (2027-2032) Table 47. Global Niraparib API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Niraparib API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Niraparib API Sales Value Share by Region (2021-2026) Table 50. Global Niraparib API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Niraparib API Sales Value Share by Region (2027-2032) Table 52. Global Niraparib API Market Average Price (US$/Kg) by Region (2021-2026) Table 53. Global Niraparib API Market Average Price (US$/Kg) by Region (2027-2032) Table 54. Global Niraparib API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Niraparib API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Niraparib API Sales by Country (2021-2026) & (Tons) Table 57. Global Niraparib API Sales Market Share by Country (2021-2026) Table 58. Global Niraparib API Sales by Country (2027-2032) & (Tons) Table 59. Global Niraparib API Sales Market Share by Country (2027-2032) Table 60. Global Niraparib API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Niraparib API Sales Value Market Share by Country (2021-2026) Table 62. Global Niraparib API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Niraparib API Sales Value Market Share by Country (2027-2032) Table 64. Nantong Changyou Pharmaceutical Technology Company Information Table 65. Nantong Changyou Pharmaceutical Technology Business Overview Table 66. Nantong Changyou Pharmaceutical Technology Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 67. Nantong Changyou Pharmaceutical Technology Niraparib API Product Portfolio Table 68. Nantong Changyou Pharmaceutical Technology Recent Development Table 69. Asymchem Company Information Table 70. Asymchem Business Overview Table 71. Asymchem Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 72. Asymchem Niraparib API Product Portfolio Table 73. Asymchem Recent Development Table 74. WuXi STA Company Information Table 75. WuXi STA Business Overview Table 76. WuXi STA Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 77. WuXi STA Niraparib API Product Portfolio Table 78. WuXi STA Recent Development Table 79. Valary Lab Company Information Table 80. Valary Lab Business Overview Table 81. Valary Lab Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 82. Valary Lab Niraparib API Product Portfolio Table 83. Valary Lab Recent Development Table 84. SynZeal Research Company Information Table 85. SynZeal Research Business Overview Table 86. SynZeal Research Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 87. SynZeal Research Niraparib API Product Portfolio Table 88. SynZeal Research Recent Development Table 89. Jigs chemical Company Information Table 90. Jigs chemical Business Overview Table 91. Jigs chemical Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 92. Jigs chemical Niraparib API Product Portfolio Table 93. Jigs chemical Recent Development Table 94. Dr. Reddy's Laboratories Company Information Table 95. Dr. Reddy's Laboratories Business Overview Table 96. Dr. Reddy's Laboratories Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 97. Dr. Reddy's Laboratories Niraparib API Product Portfolio Table 98. Dr. Reddy's Laboratories Recent Development Table 99. Bulat Pharmaceutical Company Information Table 100. Bulat Pharmaceutical Business Overview Table 101. Bulat Pharmaceutical Niraparib API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 102. Bulat Pharmaceutical Niraparib API Product Portfolio Table 103. Bulat Pharmaceutical Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Niraparib API Distributors List Table 107. Niraparib API Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Niraparib API Product Image Figure 2. Global Niraparib API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Niraparib API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Niraparib API Sales (2021-2032) & (Tons) Figure 5. Global Niraparib API Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Niraparib API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.98 Image Figure 10. 0.99 Image Figure 11. Global Niraparib API Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Niraparib API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Niraparib API Sales Volume Share by Type (2021-2032) Figure 14. Global Niraparib API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Niraparib API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Niraparib API Sales Value Share by Type (2021-2032) Figure 17. Tablets Image Figure 18. Capsules Image Figure 19. Other Image Figure 20. Global Niraparib API Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Niraparib API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Niraparib API Sales Volume Share by Application (2021-2032) Figure 23. Global Niraparib API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Niraparib API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Niraparib API Sales Value Share by Application (2021-2032) Figure 26. Global Niraparib API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Niraparib API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Niraparib API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Niraparib API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Niraparib API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Niraparib API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Niraparib API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Niraparib API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Niraparib API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Niraparib API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Niraparib API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Niraparib API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Niraparib API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Niraparib API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Niraparib API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Niraparib API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Niraparib API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Niraparib API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Niraparib API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 0.98
  • 0.99
Applications
  • Tablets
  • Capsules
  • Other
Companies covered
  • Nantong Changyou Pharmaceutical Technology
  • Asymchem
  • WuXi STA
  • Valary Lab
  • SynZeal Research
  • Jigs chemical
  • Dr. Reddy's Laboratories
  • Bulat Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Niraparib API Sales Value (2021-2032)
  4. 1.2.2 Global Niraparib API Sales Volume (2021-2032)
  5. 1.2.3 Global Niraparib API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Niraparib API Market Dynamics
  1. 2.1 Niraparib API Industry Trends
  2. 2.2 Niraparib API Industry Drivers
  3. 2.3 Niraparib API Industry Opportunities and Challenges
  4. 2.4 Niraparib API Industry Restraints
3 Niraparib API Market by Company
  1. 3.1 Global Niraparib API Company Revenue Ranking in 2025
  2. 3.2 Global Niraparib API Revenue by Company (2021-2026)
  3. 3.3 Global Niraparib API Sales Volume by Company (2021-2026)
  4. 3.4 Global Niraparib API Average Price by Company (2021-2026)
  5. 3.5 Global Niraparib API Company Ranking (2024-2026)
  6. 3.6 Global Niraparib API Company Manufacturing Base and Headquarters
  7. 3.7 Global Niraparib API Company Product Type and Application
  8. 3.8 Global Niraparib API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Niraparib API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Niraparib API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Niraparib API Market by Type
  1. 4.1 Niraparib API Type Introduction
  2. 4.1.1 0.98
  3. 4.1.2 0.99
  4. 4.2 Global Niraparib API Sales Volume by Type
  5. 4.2.1 Global Niraparib API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Niraparib API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Niraparib API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Niraparib API Sales Value by Type
  9. 4.3.1 Global Niraparib API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Niraparib API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Niraparib API Sales Value Share by Type (2021-2032)
5 Niraparib API Market by Application
  1. 5.1 Niraparib API Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Capsules
  4. 5.1.3 Other
  5. 5.2 Global Niraparib API Sales Volume by Application
  6. 5.2.1 Global Niraparib API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Niraparib API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Niraparib API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Niraparib API Sales Value by Application
  10. 5.3.1 Global Niraparib API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Niraparib API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Niraparib API Sales Value Share by Application (2021-2032)
6 Niraparib API Regional Sales and Value Analysis
  1. 6.1 Global Niraparib API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Niraparib API Sales by Region (2021-2032)
  3. 6.2.1 Global Niraparib API Sales by Region: 2021-2026
  4. 6.2.2 Global Niraparib API Sales by Region (2027-2032)
  5. 6.3 Global Niraparib API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Niraparib API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Niraparib API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Niraparib API Sales Value by Region (2027-2032)
  9. 6.5 Global Niraparib API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Niraparib API Sales Value (2021-2032)
  12. 6.6.2 North America Niraparib API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Niraparib API Sales Value (2021-2032)
  15. 6.7.2 Europe Niraparib API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Niraparib API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Niraparib API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Niraparib API Sales Value (2021-2032)
  21. 6.9.2 South America Niraparib API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Niraparib API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Niraparib API Sales Value Share by Country, 2025 VS 2032
7 Niraparib API Country-level Sales and Value Analysis
  1. 7.1 Global Niraparib API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Niraparib API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Niraparib API Sales by Country (2021-2032)
  4. 7.3.1 Global Niraparib API Sales by Country (2021-2026)
  5. 7.3.2 Global Niraparib API Sales by Country (2027-2032)
  6. 7.4 Global Niraparib API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Niraparib API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Niraparib API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Niraparib API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Niraparib API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Niraparib API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Niraparib API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Niraparib API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Niraparib API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Niraparib API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Niraparib API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Niraparib API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Niraparib API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Niraparib API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Niraparib API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Niraparib API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Niraparib API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Niraparib API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Niraparib API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Niraparib API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Niraparib API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Niraparib API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Niraparib API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Niraparib API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Niraparib API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Niraparib API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Niraparib API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Niraparib API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Niraparib API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Niraparib API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Niraparib API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Niraparib API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Niraparib API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Niraparib API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Niraparib API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Niraparib API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Niraparib API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Niraparib API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Niraparib API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Niraparib API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Niraparib API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Niraparib API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Niraparib API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Niraparib API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Niraparib API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Niraparib API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Niraparib API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Niraparib API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Niraparib API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Niraparib API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Niraparib API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Niraparib API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Niraparib API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Niraparib API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Niraparib API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Niraparib API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Niraparib API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Niraparib API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Niraparib API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Niraparib API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Niraparib API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Niraparib API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Niraparib API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Niraparib API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Niraparib API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Niraparib API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Niraparib API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Niraparib API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Niraparib API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Niraparib API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Niraparib API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Niraparib API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Niraparib API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Niraparib API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Niraparib API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Niraparib API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Niraparib API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Niraparib API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Niraparib API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Niraparib API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Niraparib API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Niraparib API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Niraparib API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Niraparib API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Niraparib API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Niraparib API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Niraparib API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Nantong Changyou Pharmaceutical Technology
  2. 8.1.1 Nantong Changyou Pharmaceutical Technology Company Information
  3. 8.1.2 Nantong Changyou Pharmaceutical Technology Business Overview
  4. 8.1.3 Nantong Changyou Pharmaceutical Technology Niraparib API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Nantong Changyou Pharmaceutical Technology Niraparib API Product Portfolio
  6. 8.1.5 Nantong Changyou Pharmaceutical Technology Recent Developments
  7. 8.2 Asymchem
  8. 8.2.1 Asymchem Company Information
  9. 8.2.2 Asymchem Business Overview
  10. 8.2.3 Asymchem Niraparib API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Asymchem Niraparib API Product Portfolio
  12. 8.2.5 Asymchem Recent Developments
  13. 8.3 WuXi STA
  14. 8.3.1 WuXi STA Company Information
  15. 8.3.2 WuXi STA Business Overview
  16. 8.3.3 WuXi STA Niraparib API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 WuXi STA Niraparib API Product Portfolio
  18. 8.3.5 WuXi STA Recent Developments
  19. 8.4 Valary Lab
  20. 8.4.1 Valary Lab Company Information
  21. 8.4.2 Valary Lab Business Overview
  22. 8.4.3 Valary Lab Niraparib API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Valary Lab Niraparib API Product Portfolio
  24. 8.4.5 Valary Lab Recent Developments
  25. 8.5 SynZeal Research
  26. 8.5.1 SynZeal Research Company Information
  27. 8.5.2 SynZeal Research Business Overview
  28. 8.5.3 SynZeal Research Niraparib API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SynZeal Research Niraparib API Product Portfolio
  30. 8.5.5 SynZeal Research Recent Developments
  31. 8.6 Jigs chemical
  32. 8.6.1 Jigs chemical Company Information
  33. 8.6.2 Jigs chemical Business Overview
  34. 8.6.3 Jigs chemical Niraparib API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jigs chemical Niraparib API Product Portfolio
  36. 8.6.5 Jigs chemical Recent Developments
  37. 8.7 Dr. Reddy's Laboratories
  38. 8.7.1 Dr. Reddy's Laboratories Company Information
  39. 8.7.2 Dr. Reddy's Laboratories Business Overview
  40. 8.7.3 Dr. Reddy's Laboratories Niraparib API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Reddy's Laboratories Niraparib API Product Portfolio
  42. 8.7.5 Dr. Reddy's Laboratories Recent Developments
  43. 8.8 Bulat Pharmaceutical
  44. 8.8.1 Bulat Pharmaceutical Company Information
  45. 8.8.2 Bulat Pharmaceutical Business Overview
  46. 8.8.3 Bulat Pharmaceutical Niraparib API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bulat Pharmaceutical Niraparib API Product Portfolio
  48. 8.8.5 Bulat Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Niraparib API Value Chain Analysis
  2. 9.1.1 Niraparib API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Niraparib API Sales Mode & Process
  6. 9.2 Niraparib API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Niraparib API Distributors
  9. 9.2.3 Niraparib API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst